Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

Nathaniel R. West,Ahmed N. Hegazy,Owens Bmj.,Samuel J. Bullers,B. Linggi,Sofia Buonocore,M Coccia,Dieter Görtz,S This,K Stockenhuber,Johanna Pott,Matthias Friedrich,Grigory Ryzhakov,Frédéric Baribaud,Carrie Brodmerkel,C. Cieluch,Nahid Rahman,Gerhard Müller-Newen,Raymond J. Owens,Anja A. Kühl,Kevin J. Maloy,Scott E. Plevy,Satish Keshav,Travis Spl.,Fiona Powrie

Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.

2017

Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Keywords:

Tumor necrosis factor alpha
Immunology
intestinal inflammation
Inflammatory bowel disease
Oncostatin M
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations